Department of Medicine Faculty
Bio
Administrator Info
Name: Admin
Phone: 612-624-9996
Email: idimdivision@umn.edu
Fax: 612-625-4410
Summary:
Dr. Gulleen is a physician-scientist trained in global health, epidemiology, implementation science, and immunocompromised infectious diseases. She has a particular interest in infections that occur in the oncology and hematopoietic stem cell transplant populations. Her research focuses on defining the microbiology of febrile illness among patients receiving cancer treatment in sub-Saharan Africa, with the goal of developing locally relevant infection management guidelines that will decrease infection-related mortality in this patient population. In addition, she uses implementation science to improve the diagnosis and management of infections and build antimicrobial stewardship programs for patients receiving cancer treatment in resource-limited settings. Dr. Gulleen is the PI of a Center for AIDS Research New Investigator Award investigating gastrointestinal colonization with multi-drug resistant bacteria among patients receiving cancer treatment in Uganda. She is also the PI of a study which uses principles of implementation science to identify and address barriers to rapid delivery of guideline-recommended antibiotics for Ugandan patients with neutropenic fever, funded by Fogarty International.
Dr. Gulleen is passionate about working with local clinicians and researchers to build collaborative, multi-disciplinary global health research programs that directly inform patient care. She has longstanding multidisciplinary clinical and research collaborations with colleagues at the Uganda Cancer Institute in Kampala, Uganda.
Expertise: Transplant Infectious Diseases; Tropical Medicine; Implementation Science; Epidemiology; Global Health
Research Summary
Microbiology, diagnosis, and management of febrile illness among patients with cancer; HIV-related opportunistic infections in oncology populations; Using implementation science to improve infection management in resource-limited settings; Antimicrobial stewardship in the immunocompromised host
Teaching Summary
Global Health; Implementation science; Antibiotic use and antimicrobial stewardship
Clinical Summary
Infectious diseases in the immunocompromised host; Antimicrobial stewardship; Clinical tropical medicine
Bio
Administrator Info
Name: Karen Fitz
Phone: 612-626-5906
Email: fitz0355@umn.edu
Summary
Dr. Gupta is a gastrointestinal oncologist, a symptom management enthusiast, and a health services researcher. His research specifically examines cancer care access and delivery, the costs of cancer care, and the hidden burdens imposed on and faced by people with cancer and their caregivers while receiving this care.
Research Summary
Dr. Gupta’s research is at the intersection of oncology, supportive care, and care delivery. His primary focus is identifying, understanding, and improving the ‘’hidden toxicities’’ of receiving cancer care. Many of the burdens of a cancer diagnosis and treatment on a patient and caregivers extend beyond the physical effects of the cancer itself. These include financial toxicity and caregiver burdens. The ultimate goal of this work is to improve the quality of life for people with cancer and their loved ones.
Teaching Summary
Gastrointestinal Cancer; Symptom Control; Supportive Care
Clinical Summary
gastrointestinal cancer (esophageal, stomach/gastric, gallbladder, biliary tract); cholangiocarcinoma; liver cancer; hepatocellular cancer; pancreatic cancer; neuroendocrine cancer; gastrointestinal stromal tumor; small bowel cancer; appendix cancer; colorectal cancer; anal cancer
Education
Professional Memberships
Bio
Dr. Sergey Gurevich is an interventional cardiologist with University of Minnesota Health. Dr. Gurevich competed his medical school at the Medical College of Wisconsin and his residency at New York Presbyterian-Weill Cornell Medical College. He joined the University of Minnesota Cardiovascular general fellowship in July of 2015 and subsequently completed his interventional training in 2018. Following his fellowship, he was asked to join the cardiovascular section at the University of Minnesota Medical School where his clinical focus has been primarily interventional coronary procedures including complex coronary intervention with mechanical circulatory support and chronic total occlusions.His research interests have focused on improving transcatheter therapies for structural heart disease including transcatheter aortic valve replacement and transcatheter mitral therapies. His translational research has been focused on implementation of emerging technologies into clinical practice. His work has been featured at several national and international conferences with a number of publications in peer-reviewed journals.
Research Summary
Dr. Gurevich's research focus is transcatheter therapies for structural heart disease
Clinical Summary
Cardiac CT, Coronary artery disease and intervention, Coronary artery disease (stable and unstable angina, myocardial, infarction), Coronary physiology, Hemodynamics, Interventional cardiology, Invasive hemodynamics, Mechanical circulatory support, Percutaneous closure of patent foramen ovale and atrial septal defect, Pulmonary artery hypertension, Structural heart disease, Transcatheter therapies, Valvular heart disease
Languages
Bio
Dr. Alejandra Gutierrez Bernal is a Latin American woman from Columbia. She graduated from medical school in her home Bogota at the University of the Andes and completed her internal medicine residency at Cleveland Clinic in Ohio, and then came to the University of Minnesota to complete her cardiology and critical care fellowship. Following her fellowship, Dr. Gutierrez Bernal joined the faculty at the University of Minnesota more than a half a year ago and now works in the cardiac ICU taking care of post arrest patients.
Clinical Summary
Dr. Gutierrez’s clinical interest is in Critical Care Medicine and Post-ICU clinic follow-up.
Contact
Administrative Contact
Alejandra Gutierrez Bernal, MD
420 Delaware Street SE, MMC 508
Minneapolis, MN 55455
Admin: Kathy Vang (vang3630@umn.edu; 612-626-1331)
Bio
Dr. Haase is Regents’ Professor and Head, Department of Microbiology and Immunology, University of Minnesota. Dr. Haase has devoted his research career from the 1970s to the present to understanding the slow infections caused by lentiviruses from visna virus to SIV and HIV. The Haase lab pioneered approaches to visualizing animal lentivirus and HIV infections in vivo to reveal HIV lymphoid tissue reservoirs; covert infections enabling persistence despite immune defenses and ART; mechanisms of CD4 T cell depletion that limit immune reconstitution; and transmission mechanisms that lay foundations for developing effective microbicides and vaccines. His lab is currently exploring the role of productive and latent infections in resting CD4 T cells during ART with the aim of better Rx to move us closer to a functional cure for HIV infection. Dr. Haase is a NIH NINDS Javits Awardee and two-time recipient of an NIH MERIT Award for his work on HIV, an elected member of the National Academy of Medicine and American Academy of Microbiology, and a Fellow of the AAAS. He has served on the NIH Councils of NIAID and OAR, as the first Chair of the AIDS Research Advisory Council, and as Chair of the US Delegation for the U.S. Japan Cooperative Medical Sciences Program.
Research Summary
Viral pathogenesis, HIV My laboratory investigates the pathogenesis, treatment and prevention of lentiviral immunodeficiency infections caused by HIV-1 and its simian relative, SIV, using such technologies as in situ hybridization, in situ tetramer staining and quantitative image analysis to visualize infection and the hosts' cellular immune response in tissues. Much of our recent work has focused on sexual mucosal transmission and the acute stage of SIV infection, the roles of "resting" and activated CD4 T cells in establishing infection, and the mechanisms of the massive depletion of CD4 T cells in the gut. Going forward, these studies provide a foundation for studies of the correlates of protection for attenuated vaccines, and the development of vaccines and microbicides to prevent transmission. My laboratory has also undertaken a comprehensive microarray analysis of HIV-1 and SIV infections with the objectives of understanding pathogenesis and identifying novel targets for treatment and prevention. Current efforts focus on broadening the microarray analysis to encompass the early through late stages of HIV-1 infection, and mapping genes identified in the analysis to gain insight into their function in HIV-1 infected lymphatic tissues, the principal sites of virus production, persistence and pathology.
Recent Publications:
- Kroon E, Chottanapund S, Buranapraditkun S, Sacdalan C, Colby DJ, Chomchey N, Prueksakaew P, Pinyakorn S, Trichavaroj R, Vasan S, Manasnayakorn S, Reilly C, Helgeson E, Anderson J, David C, Zulk J, de Souza M, Tovanabutra S, Schuetz A, Robb ML, Douek DC, Phanuphak N, Haase A, Ananworanich J, Schacker TW. Paradoxically Greater Persistence of HIV RNA-Positive Cells in Lymphoid Tissue When ART Is Initiated in the Earliest Stage of Infection. J Infect Dis. 2022 Jun 15;225(12):2167-2175. doi: 10.1093/infdis/jiac089. PMID: 35275599; PMCID: PMC9200151.
- Wietgrefe SW, Duan L, Anderson J, Marqués G, Sanders M, Cummins NW, Badley AD, Dobrowolski C, Karn J, Pagliuzza A, Chomont N, Sannier G, Dubé M, Kaufmann DE, Zuck P, Wu G, Howell BJ, Reilly C, Herschhorn A, Schacker TW, Haase AT. Detecting Sources of Immune Activation and Viral Rebound in HIV Infection. J Virol. 2022 Aug 10;96(15):e0088522. doi: 10.1128/jvi.00885-22. Epub 2022 Jul 20. PMID: 35856674; PMCID: PMC9364797.
- Luca Schifanella, Jodi Anderson, Garritt Wieking, Peter J Southern, Spinello Antinori, Massimo Galli, Mario Corbellino, Alessia Lai, Nichole Klatt, Timothy W Schacker, Ashley T Haase, The Defenders of the Alveolus Succumb in COVID-19 Pneumonia to SARS-CoV-2 and Necroptosis, Pyroptosis, and PANoptosis, The Journal of Infectious Diseases, 2023;, jiad056, https://doi.org/10.1093/infdis/jiad056
- Wu G, Zuck P, Goh SL, Milush JM, Vohra P, Wong JK, Somsouk M, Yukl SA, Shacklett BL, Chomont N, Haase AT, Hatano H, Schacker TW, Deeks SG, Hazuda DJ, Hunt PW, Howell BJ. Gag p24 Is a Marker of Human Immunodeficiency Virus Expression in Tissues and Correlates With Immune Response. J Infect Dis. 2021 Nov 16;224(9):1593-1598. doi: 10.1093/infdis/jiab121. PMID: 33693750; PMCID: PMC8599810.
Contact
Address
2-115 MRF689 23rd Ave SE
Minneapolis, MN 55455
Bio
Administrator Info
Name: DHM Admin Team
Email: dhmadmin@umn.edu
Phone Number: 612-624-0579
Fax Number: 612-624-3189
Summary
Dr. Jessica Hane is an internal medicine and pediatric hospitalist. She attended the University of Iowa Carver College of Medicine and completed her internal medicine and pediatrics residency training at the University of Minnesota.
Research Summary
Physician Advocacy Medical education Health disparities
Clinical Summary
Hospital Medicine; Addiction Medicine
Bio
Administrator Info
Name: DHM Admin Team
Email: dhmadmin@umn.edu
Phone Number: 612-624-0579
Fax Number: 612-624-3189
Summary
I completed Medical School at Marshall University in West Virginia and completed my Internal Medicine/Pediatric Residency training at Ohio State University Medical Center.
Professional Memberships
Bio
Administrator Info
Email: endofixer@umn.edu
Mail: 420 Delaware Street SE, MMC 101, Minneapolis, MN 55455
Summary
Dr. Harindhanavudhi graduated with a medical degree from Siriraj hospital, Mahidol University in Thailand in 2003. After which she worked in a community hospital in rural Thailand before becoming a research assistant in the Department of Physiology at Mahidol University. Dr. Harindhanavudhi went on to complete an internal medicine residency at the University of Illinois at Chicago/Advocate Christ Medical Center in 2009 and a fellowship in Endocrinology at the University of Minnesota in 2012. Her research interests include diabetes and cardiometabolic complication, obesity and calcium metabolism.
Research Summary
Diabetic nephropathy Obesity Calcium metabolism
Clinical Summary
Diabetes; Diabetes nephropathy; Obesity; Calcium metabolism
Bio
Administrator Info
Name: Admin
Phone: 612-624-9996
Fax: 612-625-4410
Email: idimdivision@umn.edu
Mail: Mayo Memorial Building, MMC 250, 420 Delaware Street S.E., Minneapolis, MN 55455
Summary
Dr. Hart performed his dissertation research in the Center for Immunology at the University of Minnesota. Postdoctoral work at the NIH has focused on malaria research. His primary interest is centered on innate immunity, particularly NK cells, in malaria. Using a basic immunology approach, he collaborates with on-going studies in malaria endemic regions of Africa to try to understand protective and pathological mechanisms of this deadly disease.
Research Summary
Basic human immunology Malaria immunity and pathogenesis Antibody mediated immunity Innate inflammation regulation Human immunology of malaria There is no approved vaccine for malaria, and there are still many fundamental unanswered questions for malaria immunity. The Hart lab believes many of these unanswered questions lie where innate immunity intersects with the adaptive immune system. Using a basic immunology approach, they collaborate with on-going studies in malaria endemic regions of Africa. Current malaria projects center around understanding the mechanism of antibody mediated immunity and innate regulatory mechanisms (or lack thereof) in pathological immune responses. We use human subject samples primarily for our studies, and we are also developing novel mouse models to better understand in vivo dynamics where needed.Dr. Hart is a new Primary Investigator in the MICaB program and is excited to train and mentor the next generation of MICaB graduate students. Rotation spots are currently available for the 2017 incoming class. Please apply via email (hart0792@umn.edu).
Clinical Summary
Vaccine development; Immunotherapy
Education
Bio
Dr. Brett Hendel-Paterson has been the director of the University of Minnesota Global Medicine Pathway since 2016. He graduated from the University of Minnesota-Duluth for medical school and completed a combined internal medicine/pediatrics residency at the University of Minnesota, later becoming board-certified in hospice and palliative medicine. Since 2010 he has been a co-director for the University of Minnesota Global Health Course, a course approved by the American Society of Tropical Medicine and Hygiene as a diploma course. He is a clinician educator and practices hospital medicine and palliative care at HealthPartners Regions Hospital, in St. Paul Minnesota. He works at the HealthPartners Tropical Medicine and Travel Clinic. His areas of interest include clinical tropical medicine education, care of immigrants and refugees, medical education in general, teaching approaches to clinical care in low-resource settings, use of clinical simulation for training, medical improv, reducing health disparities, physician wellness and burnout, patient experience and communication, and navigating language or cultural barriers in approaching end-of-life and advance care planning.
Bio
Administrator Info
Name: Helen Rieger
Phone: 612-624-0999
Email: riege002@umn.edu
Fax: 612-625-2174
Summary
Dr. Henke graduated from medical school at the University of Minnesota in 1983. He completed residency training in Internal Medicine in 1986 and fellowship sub-specialty training in Pulmonary and Critical Care Medicine in 1989, both at the University of Minnesota. He is a professor in the Pulmonary and Critical Care Medicine Division. Clinical activities and interests include subspecialty pulmonary clinic focusing on interstitial lung diseases. Dr. Henke's research program seeks to understand the pathogenesis of Idiopathic Pulmonary Fibrosis (IPF) at the basic science level. His research program focuses on identifying the underlying mechanisms driving IPF fibrotic progression. Recent discoveries include identification of pathological mesenchymal progenitor cells as a cell-of-origin for scar-forming IPF fibroblasts. The research program is currently focusing on elucidating epigenetic processes responsible for reprogramming IPF progenitor cells to their pathologic phenotype. Dr. Henke's research in IPF is supported by a NIH/NHLBI R01 Grant.
Clinical Summary
Interstitial lung disease with a focus on Idiopathic Pulmonary Fibrosis
Professional Memberships
Bio
Administrator Info
Name: Admin
Phone: 612-624-9996
Fax: 612-625-4410
Email: idimdivision@umn.edu
Mail: Mayo Memorial Building, MMC 250, 420 Delaware Street S.E., Minneapolis, MN 55455
Summary
Alon Herschhorn Ph.D. is an Associate Professor with tenure in the Department of Medicine at the University of Minnesota. Prior to his current faculty appointment, Dr. Herschhorn held a faculty position as Instructor in Microbiology and Immunobiology at Dana-Farber Cancer Institute and Harvard Medical School, where he developed strong research program on virus entry and fate, with a specific focus on HIV-1. Dr. Herschhorn successfully obtained the prestigious Rothschild and amfAR fellowships as well as external funding, and developed productive collaborations with different research groups in USA and Canada.Dr. Herschhorn is leading a new research group in the Division of Infectious Diseases and International Medicine that will develop new tools to study, at the molecular and cellular levels, the mechanisms underlying virus-host interactions. His previous work provided new insights into the entry process of HIV-1, the conformational dynamics of the HIV-1 envelope glycoproteins, and the cellular processes that contribute to the fate of viral infection.
Research Summary
My laboratory is working on exciting directions to understand and target HIV-1 host interactions at the molecular and cellular levels. We use interdisciplinary approaches at the interface of synthetic and molecular virology, immunology and cell biology to gain new insights into complex biological processes with the aim of translating these insights into novel therapies and vaccines to treat and prevent viral infections.
Clinical Summary
HIV-1 infection and latency; HIV-1 vaccine and eradication
Education
Bio
I was raised in Detroit, Michigan; and attended the University of Michigan for college and medical school. I came to the University of Minnesota in 1978 for my Internal Medicine residency—and have spent my entire adult life here. My professional career has focused on three themes: Caring for patients with lung disease: I have served as medical director of the University of Minnesota lung transplant program since its inception in 1986; since then we have performed more than 1,000 lung transplants.Advancing scientific knowledge related to organ transplant medicine: I have been PI of funded NIH P01 and R01 grants; as well as Co-I on multiple other research projects. I have authored or co-authored more than 200 peer-reviewed publications. At present, I am the site-PI for the Cystic Fibrosis Lung Transplant Consortium; and for the CMS-sponsored registry of extracorporeal photopheresis for bronchiolitis obliterans syndrome after lung transplantationMentoring and teaching medical students, trainees, and junior faculty members: Currently, I enjoy being a member of our medical school Faculty Advisor program--which has been immensely effective, earning a 95% "approval rating" from our students! When not working, I enjoy relaxing with my family and friends, exercise, music, and travel.
Clinical Summary
Lung Transplantation Medicine
Bio
Administrator Info
Name: DHM Admin Team
Email: dhmadmin@umn.edu
Summary
Dr. Brian Hilliard has a specific interest in health disparities and health policy. He is actively involved in promoting physician advocacy. His current projects include studying the impact of medicaid expansion on high utilizers and training physicians for advocacy and community engagement.
Research Summary
Health Disparities
Clinical Summary
Hospital Medicine
Bio
Administrator Info
Name: GI Division
Phone: 612-625-8999
Email: gidivision@umn.edu
Mail: 420 Delaware Street SE, MMC 36, Minneapolis, MN 55455
Summary
Dr. Howard graduated from medical school in Philadelphia, PA at Jefferson Medical College in 2007. He completed his internal medicine residency and a chief resident year in 2011 at the University of Minnesota where he developed a passion for teaching medical students and residents. He then completed a fellowship in gastroenterology at the University of Minnesota in 2014. During his time in training he developed a particular interest in treating patients with inflammatory bowel disease. As a faculty member at the University of Minnesota, Dr. Howard works closely with his patients to provide individualized care that incorporates not only the latest in medical and surgical treatment options, but also life-style and dietary modifications.
Education
Fellowships, Residencies, and Visiting Engagements
Honors and Recognition
Professional Memberships
Bio
Administrator Info
Name: DHM Admin Team
Email: dhmadmin@umn.edu
Phone Number: 612-624-0579
Fax Number: 612-624-3189
Summary
Dr. Hozayen graduated school of medicine at Cairo University, Egypt in 2004. He completed his first training program in general cardiovascular science in Dar Al Fouad Hospital in Egypt in 2009. He then served as a junior faculty of cardiovascular medicine in Egypt.Dr.Hozayen moved to the USA where he did a two year research fellowship in advanced heart failure and mechanical circulatory support at the University of Minnesota in 2010. He went on for another one year research fellowship at Yale University Hospital in 2012. Then, he completed his first residency in the USA in internal medicine residency training at St Vincent's Medical Center in Bridgeport, CT in 2017. He took his first job at Sovah Health, Danville, Virginia. He practiced hospital medicine as a core faculty for internal medicine residency program and chief of internal medicine there. He eventually returened to the his home institution at the University of Minnesota in 2019 where is currently practicing as an academic hospitalist. Dr.Hozayen's primary area of clinical practice is inpatient medicine. His area of clinical focus is treatment of sepsis, occult infections, respiratory failure, cardiovascular events and encephalopathies. Dr.Hozayen takes a special pride in delievering high quality care, reduction of sepsis related morbidity and mortality, treatment of cancer complications, building a healing patient - physician relationship and adopting a patient focused approach to medical practice. Dr.Hozayen is also passionate for research related to health disparities and cultural diversity. His research focuses is on cardiovascular outcomes especially in heart failure, prediction of myocardial recovery and vascular phsiology. Ongoing studies include research related to SARS-COV-2. Dr.Hozayen's teaching experience includes small group teaching to medical students and medical residents. The focus is in clinical data navigation and critical thinking skills.
Research Summary
Health disparities Cardiovascular outcomes SARS-COV-2 outcomes
Clinical Summary
Sepsis; Respiratory failure; Heart failure; Acute kidney injury; Acute decompensated liver failure; Cardiovascular events; shock physiology and encephalopathies
Selected Presentations
Bio
Administrator Info
Name: Karen Fitz
Phone: 612-626-5906
Email: fitz0355@umn.edu
Summary
Dr. Hu is a hematologist-oncologist specializing in blood cancers such as lymphoma and leukemia. Her particular clinical and research interests are in aggressive lymphomas and immunological approaches to treating cancers, including cellular therapy (CAR-T and CAR-NK). Dr. Hu's research also focuses on expanding access to novel therapies, bone marrow transplant, and cellular therapy.
Research Summary
- Aggressive lymphomas
- Cellular therapies
- Early-phase clinical trials
- Healthcare disparities
Teaching Summary
Hematology; Immunology
Clinical Summary
Lymphomas; leukemia; cellular therapies
Honors and Recognition
Professional Memberships
Bio
Administrator Info
Name: DHM Admin Team
Email: dhmadmin@umn.edu
Phone Number: 612-624-0579
Fax Number: 612-624-3189
Summary
Dr. Huff completed medical school at the University of Oklahoma-Tulsa (OU-TU) School of Community Medicine and then internal medicine residency at Mayo Clinic Arizona. He also completed a Masters in Public Health in 2020 at OU-TU with a focus on healthcare policy and worked with the Oklahoma Policy Institute as well as the Cherokee Nation. He is interested in teaching medical students and residents how to care for patients in the hospital.
Research Summary
Healthcare policy
Teaching Summary
Hospital Medicine
Service Summary
Attitude and Commitment to Excellence Award, PGY3 (2023)
Clinical Summary
Cancer screening, Preventative health
Bio
Dr. Curtis Hughey, PhD, completed his doctoral studies at the University of Calgary in Biochemistry and Molecular Biology. During his doctoral training he received a Canadian Institutes of Health Research Doctoral Scholarship and the Izaak Walton Killam Memorial Scholarship to study the use of stem cell therapy to promote in vivo insulin sensitivity in mouse models of diet-induced obesity and heart failure. With an interest in the genetic and environment regulation of in vivo glucose control, Dr. Hughey then pursued a postdoctoral fellowship at Vanderbilt University. While at Vanderbilt, he received a Canadian Diabetes Association Postdoctoral Fellowship to test the role of liver energy state in the regulation of glucose production during exercise. This work employed a metabolic flux analysis technique that uses stable isotopes, mass spectrometry, and computational modeling to quantify in vivo metabolic fluxes. An emerging research focus for the Hughey Laboratory at the University of Minnesota is to define the role of transmethylation in the metabolic reprogramming that occurs in non-alcoholic fatty liver disease and hepatocellular carcinoma.
Research Summary
Metabolic dysregulation underlies many public health challenges of modern society. The overarching objective of research in the Hughey Laboratory is to identify pathways within complex metabolic networks that can be used for early identification of disease or targeted to prevent or treat metabolic diseases. To accomplish this aim, studies combine the use of stable isotopes, mass spectrometry, and computational modeling to quantify in vivo metabolic fluxes in genetically-engineered mice. Many studies also employ provocative stimuli such as exercise and diet to challenge metabolic networks. Areas of focus are: The role of dysregulated hepatic transmethylation in the metabolic programming that promotes non-alcoholic fatty liver disease and hepatocellular carcinoma. Regulation of hepatic glucose formation during acute exercise and in response to habitual exercise.
Bio
Administrator Info
Name: Linsey Roschen
Phone: 612-626-6553
Email: rosch053@umn.edu
Summary
Justin Hwang received his undergraduate degree at Carnegie Mellon University in chemical engineering. He obtained his PhD degree in biochemistry in studying critical regulators of cell differentiation, survival and tumorigenesis. In 2020, he has completed his post-doctoral training at Dana-Farber Cancer Institute, Broad Institute of MIT and Harvard. During this time, he developed genome-scale functional and analytical approaches to identify gene targets in lethal cancers, including metastatic prostate cancers and breast. At the University of Minnesota, his laboratory will examine novel regulatory genes that drive malignant behavior of cancers utilizing high throughput functional and clinical informatic approaches.
Research Summary
Cancer Functional Genomics Cancer Genomics Precision Therapeutics Cell Signaling Transcription
Research Interest: Solid Tumor
Clinical Summary
Prostate Cancer; Cancer Progression, Precision Therapeutics
Bio
Administrator Info
Name: Helen Rieger
Phone: 612-624-0999
Email: riege002@umn.edu
Fax: 612-625-2174
Clinical Summary
Sleep Medicine; Health Care Delivery; Novel Approaches in Sleep Apnea; Patient Care Strategies and Guidelines; Respiratory Physiology; Respiratory Failure; Respiratory Control Disorders; Disorders of Heart-Lung Interaction
Bio
Administrator Info
Name: Ms. J. Knapp
Phone: 612-626-1422
Fax: 612-625-6919
Email: jknapp@umn.edu
Mail: 420 Delaware Street SE, MMC 480, Minneapolis, MN 55455
Summary
Dr. Damé Idossa is an Assistant Professor of Medicine and a Breast Oncologist in the Division of Hematology and Oncology at the University of Minnesota. Dr. Idossa is a native of Ethiopia and immigrated to Minnesota at the age of 8. Dr. Idossa is a passionate advocate for diversity and inclusion and has a long-standing commitment to serving vulnerable populations. Her research interests focus on disparities in cancer care, breast cancer in young women, and increasing access to clinical trials. She also studies workforce development, particularly the mentorship experiences of underrepresented trainees in hematology/oncology subspecialties. Dr. Idossa has received many awards to support her research, including a merit award from the ASCO foundation and a T32 research fellowship from the NIH. She has published numerous articles in medical journals related to her research interests.
Research Summary
- Breast Cancer
- Health Disparities
- Workforce Diversity
Teaching Summary
Breast Cancer
Clinical Summary
Breast Cancer
Professional Memberships
Bio
Administrator Info
Name: Drew Keup
Email: keupx013@umn.edu
Summary
Dr. Jacob Ijdo received his clinical training at Yale University School of Medicine, where he completed both his Internal Medicine Residency and Rheumatology Fellowship. Post-fellowship, Dr. Ijdo was member of the faculty at the University of Iowa Hospitals and Clinics for 15 years. For the latter part he served as Director of the Rheumatology Fellowship program. In December 2014 Dr. Ijdo moved to Australia, where he became Director of the Rheumatology Department at the Gold Coast University Hospital in Queensland. He was also the Supervisor of Advanced Trainees at Gold Coast University Hospital.
Research Summary
Dr. Ijdo has research interests in the areas of vasculitis and the pathogenesis of tick-borne illness and was awarded an R01 on "Subverted host cell signaling by AnkA in Anaplasma phagocytophilum infection" in 2009. The study investigated the effect of the virulence factor AnkA on host signaling pathways, resulting in inhibition of the respiratory burst and delay of neutrophil apoptosis.
Clinical Summary
Vasculitis, pathogenesis of tick-borne illness
Bio
Administrator Info
Name: Helen Rieger
Phone: 612-624-0999
Email: riege002@umn.edu
Fax: 612-625-2174
Summary
Dr. Ingbar joined the Office of Faculty Affairs in 2022, as Assistant Dean for Faculty Development and Mentoring, providing leadership and strategic direction for mentoring and career development for faculty members across the school. Dr. Ingbar is the Director of Research Education, Training, and Career Development Core in the Clinical and Translational Science Institute (CTSI). Prior to this OFA role, he served for more than 20 years as Director of the Pulmonary, Allergy, Critical Care & Sleep Division in the Department of Medicine
Dr. Ingbar received his MD from Harvard Medical School, and was an Internal Medicine Resident and Chief Resident at the University of Washington before completing his Pulmonary & Critical Care fellowship at Yale University. In addition, he is a physician scientist who focuses on understanding how the lung is repaired after injury and how this compares to lung development. He is Principal Investigator of the CTSI K Program and MPI of the Lung Biology T32 training grant, now in year 29. He served as President of the American Thoracic Society (ATS) and the Association of Pulmonary & Critical Care Medicine Program Directors and as a member of the ABIM Pulmonary Board. He is a member of the NHLBI Council and previously led the ATS Physician Scientist
Dr. Ingbar is the Principal Investigator for research training provided to pre-doctoral students and post-doctoral MD and PhD fellows through a NHLBI training grant.
Clinical Summary
Acute lung injury/ARDS; Respiratory failure; Pulmonary embolism; Hemoptysis; Critical care; Pulmonary edema
Bio
Administrator Info
Name: Ashley Fuchs
Phone: 612-624-0999
Email: fuchs@umn.edu
Fax: 612-625-2174
Summary
Dr. Ingraham’s clinical expertise is in the care of critically ill patients. Dr. Ingraham is a health services researcher with an interest in evaluating and improving patient outcomes by enhancing the ICU team’s care delivery and supporting multidisciplinary care coordination.
He is particularly interested in assessing variation of evidence-based practices and identifying ways to better facilitate or mitigate barriers to provider evidence-based care to critically ill patients. His prior work has included identifying risk factors for prolonged critical illness, evaluating ICU outcomes over time, investigating the efficacy of multiple COVID-19 therapies, and measuring multiple healthcare disparities in hospitalized and critically ill patients.
Research Summary
- Critical illness outcome
- Variation in evidence-based practices
- Healthcare teamwork
- Patient centered care
Clinical Summary
ICU outcomes, chronic critical illness, end-of-life care
Education
Fellowships, Residencies, and Visiting Engagements
Honors and Recognition
Professional Memberships
Bio
Administrator Info
Name: DHM Admin Team
Email: dhmadmin@umn.edu
Phone Number: 612-624-0579
Fax Number: 612-624-3189
Summary
Dr. Jaffer is interested in global health and addressing health disparities. Additionally, he has a strong interest in teaching and in medical education.
Research Summary
Medical education Health disparities Global Health
Clinical Summary
Hospital Medicine
Bio
Administrator Info
Name: DHM Admin Team
Email: dhmadmin@umn.edu
Phone Number: 612-624-0579
Fax Number: 612-624-3189
Summary
Dr. Jain completed her medical schooling from Grant Medical College and Internal Medicine Residency from Atlantic City Medical Center in New Jersey in 2002 scoring in the 10th decile in the Internal Medicine Board Certification exam. She is Board Certified in Internal Medicine and has 18+ years of clinical experience as a General Internist and Hospitalist.
Research Summary
Quality Improvement Projects to help improve quality of care provided to hospitalized patients and improve outcomes Link between antiretroviral therapy and development of metabolic syndrome in HIV infected patients: 2002 Geriatric Care, Nanotechnology and Immunotherapy, Metabolic syndrome and Obesity
Clinical Summary
Hospital medicine; Geriatric care; Critical care
Bio
Administrator Info
Name: Helen Rieger
Phone: 612-624-0999
Email: riege002@umn.edu
Fax: 612-625-2174
Summary
I earned my medical degree from Tishreen University in Syria in 2010. Subsequently, I relocated to the United States in 2012 and joined Mayo Clinic as a postdoctoral research fellow, concentrating on cardiovascular aging research. Following this, I successfully completed my internal medicine residency training at the University of South Dakota in 2017. I concluded my fellowship training in pulmonary medicine and critical care at the University of Minnesota in 2023.
Research Summary
Interstitial Lung Diseases (ILD); identification of innovative clinical assessments capable of gauging the progression of ILD; clinical translational research
Creative Activity Summary
Interstitial Lung Diseases (ILD); employing a comprehensive multidisciplinary approach
Teaching Summary
Interstitial Lung Disease (ILD); progression of ILD; clinical translational research
Bio
Dr. Jhun received her Ph.D. degree from the Kyung Hee University School of Medicine in Seoul, Republic of Korea. She completed her postdoctoral training at Harbor-UCLA Medical Center and University of Rochester. Subsequently, she worked as an Instructor at Thomas Jefferson University and as an Assistant Professor at Rhode Island Hospital and Brown University. Dr. Jhun joined the University of Minnesota faculty in 2018 as an Assistant Professor at the Lillehei Heart Institute, Cardiovascular Division, Department of Medicine. Her research interests focus on the cellular signaling mechanisms underlying abnormal mitochondrial morphology and mitochondrial dysfunction that contributes to the development of heart failure.
Research Summary
Focus on the cellular signaling mechanisms underlying abnormal mitochondrial morphology and mitochondrial dysfunction that contributes to the cardiomyocyte death, cardiac fibroblast proliferation, and the development of heart failure. Elucidation of these regulatory mechanisms will facilitate the design of novel therapeutic targets for the pharmacological management of heart failure.
Contact
Administrative Contact
Esther Almeida
ealmeida@umn.edu
2231 6th Street SE, 4-129
Minneapolis, MN 55455
Bio
Administrator Info
Name: DHM Admin Team
Email: dhmadmin@umn.edu
Phone Number: 612-624-0579
Fax Number: 612-624-318
Bio
My practice is committed to caring for people with blood cancers, especially when bone marrow transplantation or cellular therapy is required. We live in an era where the treatment options are expanding rapidly for patients with acute leukemia, myeloid diseases, and other blood cancers. I believe the best care is determined after considering a patient and family's preferences and values. Our Bone Marrow Transplant and Cell Therapy Program at the University of Minnesota strives to provide the best medical care possible through the innovative investigation into new and better treatment options and by incorporating discoveries into our daily medical care.My interest in helping people with blood cancers includes efforts to improve recovery through guided survivorship. The treatment of blood cancers can be a long and challenging journey for some people, who may be cured, but not recovered after treatment is complete. I am interested in developing survivorship care that will give patients and families the tools and support needed to regain a long, happy, and healthy life.
Research Summary
Clinical Trials Supportive Care Treatment Toxicities Survivorship
Clinical Summary
Blood Cancers; Hematopoietic Stem Cell Transplantation
Bio
Dr. Rajat Kalra completed his medical degree in the United Kingdom. Dr. Kalra then remained in the U.K. to complete the British equivalent of internship before moving to the United States to continue his postgraduate medical training.In the United States, Dr. Kalra completed his internal medicine residency at the University of Alabama at Birmingham before moving on to complete his cardiology and advanced cardiac imaging fellowships at the University of Minnesota. During his fellowship, he also sought formal training in clinical epidemiology and biostatistics at the University of Minnesota's School of Public Health.
Research Summary
General cardiology Cardiac imaging Heart failure and cardiac arrest.
Clinical Summary
General cardiology; cardiac imaging; heart failure and cardiac arrest
Bio
Administrator Info
Name: DHM Admin Team
Email: dhmadmin@umn.edu
Phone Number: 612-624-0579
Fax Number: 612-624-3189
Summary
Pediatrics, Internal Medicine, Chief resident of internal medicine.
Languages
Bio
Dr. Kamdar is an Assistant Professor of Medicine in the Cardiovascular Division of the Department of Medicine at the University of Minnesota. She received her M.D. from the University of Minnesota Medical School. She completed her training in internal medicine and cardiovascular disease at the University of Minnesota through the Physician-Scientist Training Pathway, in which she pursued a Ph.D. in Integrative Biology and Physiology. She completed her advanced heart failure, heart transplant, and mechanical circulatory support fellowship at the Cleveland Clinic. Her clinical and research interests focus on cardiomyopathy associated with neuromuscular disorders, such as muscular dystrophies, and clinical and translational research in mechanical circulatory support.
Research Summary
Cardiac Calcium Regulation Muscular Dystrophy Associated Cardiomyopathy Human induced pluripotent stem cell research Myocardial structural proteins Mechanical circulatory support Kamdar Lab Website
Clinical Summary
Advanced heart failure, Advanced hemodynamic support, Cardiac transplant/Mechanical Circulatory Support, Heart failureHeart transplantation and regeneration, Hypertrophic cardiomyopathy, Mechanical circulatory support, Muscular dystrophy associated cardiomyopathy, Right ventricular dysfunction, Women's heart health
Bio
Administrator Info
Name: Linsey Roschen
Phone: 612-626-6553
Email: rosch053@umn.edu
Summary
Dr. Kao graduated from the Warren Alpert Medical School of Brown University and completed combined residency in internal medicine and pediatrics at ChristianaCare and Nemours Children's Hospital in Delaware, chief residency in internal medicine at ChristianaCare, pediatric hematology/oncology fellowship at UCLA David Geffen School of Medicine, and adult hematology fellowship at the University of Minnesota. He was previously a faculty member at UCLA, based at Mattel Children's Hospital in Los Angeles and Miller Children's and Women's Hospital in Long Beach and specializing in pediatric hematology/oncology and pain and palliative care. He joins the University of Minnesota specializing in non-malignant hematology and the use of hematopoietic cell transplantation and gene therapy for a variety of diseases.
Research Summary
- Hematopoietic cell transplantation and gene therapy for non-malignant disorders including sickle cell disease and thalassemia
- Supportive care for hematopoietic stem cell transplantation
Teaching Summary
Resident, fellow, and student education in general hematology
Clinical Summary
Non-malignant (benign) hematology; Hematopoietic cell transplantation Gene therapy; Bone marrow failure; Hemophagocytic lymphohistiocytosis
Education
Professional Memberships
Bio
Administrator Info
Name: Nephrology
Phone: 612-624-9444
Email: renaldiv@umn.edu
Fax: 612-626-3840
Mail: 717 Delaware Street SE, Suite 353, MMC 1932, Minneapolis, MN 55414
Summary
I obtained my medical degree from Faculte de Medecine- Universite Saint-Joseph in Beirut, Lebanon. My internal medicine residency was at Albert Einstein College of Medicine/ Montefiore Medical Center, Bronx, New York, and my Nephrology fellowship at George Washington University Hospital in Washington, DC. I also completed an International Master in Organ donation and Transplantation at the University of Barcelona, Spain. I am board certified in Internal Medicine and Nephrology and also certified since 2013 in Hypertension by the American Society of Hypertension that has since merged with the American Heart Association. I am chair of the Young Nephrologists Committee of the International Society of Nephrology (ISN) and a member of the 2021 cohort of the Emerging Leaders Program of the ISN. My clinical and research interests include Onco-Nephrology, Monoclonal Gammopathy of Renal Significance (MGRS), Hypertension, and Home Dialysis.
Research Summary
Onco-Nephrology; Monoclonal Gammopathy of Renal Significance (MGRS); Hypertension; Home Dialysis
Clinical Summary
Onco-Nephrology; Monoclonal Gammopathy of Renal Significance (MGRS); Hypertension; Home Dialysis
Bio
Administrator Info
Name: Admin
Phone: 612-624-9996
Fax: 612-625-4410
Email: idimdivision@umn.edu
Mail: Mayo Memorial Building, MMC 250, 420 Delaware Street S.E., Minneapolis, MN 55455
Summary
Dr. Kavalier completed her undergraduate medical education at the University of Illinois in Peoria and Internal Medicine residency at the University of Wisconsin in Madison. She was a member of the Global Health Pathway and traveled to Ethiopia where she practiced medicine and conducted research on hand hygiene and antibiogram development. During her fellowship in Infectious Diseases at the University of Wisconsin, she also completed the Tropical Medicine and Traveler’s Health Course through the University of Minnesota. At the University of Minnesota she will continue to work in global health research and education as well as general infectious diseases.
Research Summary
- Hand Hygiene
- Antimicrobial Stewardship and Antibiogram Development
- Rapid Diagnostic Test Development
Teaching Summary
Tropical Medicine and Traveler’s Health; Sexually Transmitted Infections; General Infectious Diseases
Clinical Summary
General Infectious Diseases; Travel-related conditions; Sexually Transmitted Infections
Fellowships, Residencies, and Visiting Engagements
Bio
I completed my Internal medicine training at the University of California San Diego, moved to Minneapolis for training in Cardiology and Advanced Cardiovascular Imaging. My clinical interests are the use of cardiac CT and cardiac magnetic resonance imaging to diagnose and treat patients with heart disease. My research interests are in the role of inflammation in heart disease.
Research Summary
Cardiac inflammation Structural Heart Disease Coronary artery disease Cardiac CT Cardiac MRI
Clinical Summary
Coronary artery disease; Cardiac CT; Cardiac MRI